Patterns of the use of advanced radiation therapy techniques for the management of bone metastases and the associated factors in Victoria

被引:7
|
作者
Fogarty, Tamara [1 ,2 ,3 ]
Tacey, Mark [1 ]
McCorkell, Giulia [2 ]
Kok, David [2 ,3 ]
Hornby, Colin [4 ]
Milne, Roger L. [5 ,6 ,7 ]
Millar, Jeremy [8 ,9 ]
Foroudi, Farshad [1 ,10 ]
Ong, Wee Loon [1 ,3 ,8 ,11 ]
机构
[1] Austin Hlth, Dept Radiat Oncol, Olivia Newton John Canc Wellness & Res Ctr, Heidelberg, Vic, Australia
[2] Univ Melbourne, Melbourne Med Sch, Melbourne, Vic, Australia
[3] Peter MacCallum Canc Ctr, Dept Radiat Oncol, Melbourne, Vic, Australia
[4] Victorian Dept Hlth, Melbourne, Vic, Australia
[5] Canc Council Victoria Melbourne, Canc Epidemiol Div, Melbourne, Vic, Australia
[6] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia
[7] Monash Univ, Sch Clin Sci Monash Hlth, Precis Med, Clayton, Vic, Australia
[8] Alfred Hlth, Dept Radiat Oncol, Melbourne, Vic, Australia
[9] Monash Univ, Cent Clin Sch, Prahran, Vic, Australia
[10] Monash Univ, Dept Epidemiol & Prevent Med, Prahran, Vic, Australia
[11] Univ Cambridge, Sch Clin Med, Cambridge, England
关键词
bone metastases; IMRT; radiation therapy; stereotactic; VMAT; EXTERNAL-BEAM RADIOTHERAPY; BODY RADIOTHERAPY; OPEN-LABEL; CANCER; RADIOSURGERY; TRIAL;
D O I
10.1111/1754-9485.13381
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction To describe the pattern of the use of advanced radiation therapy (RT) techniques, including intensity-modulated RT (IMRT), volumetric modulated arc therapy (VMAT), and stereotactic body RT (SBRT) for the management of bone metastases (BM), and the associated factors in Victoria. Methods We used a population-based cohort of patients from the state-wide Victorian Radiotherapy Minimum Data Set (VRMDS) who received RT for BM between 2012 and 2017. The primary outcome was proportion of RT courses using advanced RT techniques. The Cochran-Armitage test for trend was used to evaluate temporal trend in advanced RT use. Multinomial logistic regression was used to identify factors associated with advanced RT use. Results A total of 18,158 courses of RT were delivered to 10,956 patients-16,626 (91.6%) courses were 3D conformal RT, 857 (4.7%) IMRT/VMAT and 675 (3.7%) SBRT. There was a sharp increase in IMRT/VMAT use from <1% in 2012-2015, to 10.1% in 2016 and 16.3% in 2017 (P-trend < 0.001). Increase in SBRT use was more gradual, from 1.2% in 2012 to 4.8% in 2016 and 5.5% in 2017 for SBRT (P-trend<0.001). In multivariate analyses, year of RT was the strongest predictor of IMRT/VMAT use (OR = 41; 95%CI = 25-67; P < 0.001, comparing 2012-2013 and 2016-2017). Primary tumour type (prostate cancer) was the strongest predictor of SBRT use (OR = 6.07; 95% CI = 4.19-8.80; P < 0.001). Conclusion Overall, there was increasing trend in the use of advanced RT techniques for BM in Victoria, with a distinct pattern for IMRT/VMAT compared with SBRT - SBRT uptake was more gradual while IMRT/VMAT uptake was abrupt, occurring contemporaneously with Medicare Benefit Scheme funding changes in 2016.
引用
收藏
页码:678 / 687
页数:10
相关论文
共 50 条
  • [21] Advanced-technology radiation therapy in the management of bone and soft tissue sarcomas
    Delaney, T. F.
    RADIOTHERAPY AND ONCOLOGY, 2006, 78 : S21 - S21
  • [22] VALUE OF RADIATION THERAPY IN MANAGEMENT OF INTRACRANIAL METASTASES
    CHU, FC
    HILARIS, BB
    CANCER, 1961, 14 (03) : 577 - &
  • [23] Role of radiation therapy in brain metastases management
    Dhermain, F.
    Noel, G.
    Antoni, D.
    Tallet, A.
    CANCER RADIOTHERAPIE, 2020, 24 (6-7): : 463 - 469
  • [24] ClodronateA Review of its Use in the Prevention of Bone Metastases and the Management of Skeletal Complications Associated with Bone Metastases in Patients with Breast Cancer
    Toni M. Dando
    Lynda R. Wiseman
    Drugs & Aging, 2004, 21 : 949 - 962
  • [25] Clodronate - A review of its use in the prevention of bone metastases and the management of skeletal complications associated with bone metastases in patients with breast cancer
    Dando, TM
    Wiseman, LR
    DRUGS & AGING, 2004, 21 (14) : 949 - 962
  • [27] RADIATION THERAPY OF BONE METASTASES FROM RENAL CARCINOMA
    GLADIEUX, JR
    EVANS, JC
    INVESTIGATIVE RADIOLOGY, 1971, 6 (05) : 346 - &
  • [28] The Role of Radiation Therapy in Controlling Painful Bone Metastases
    Stephen Lutz
    Current Pain and Headache Reports, 2012, 16 : 300 - 306
  • [29] The Role of Radiation Therapy in Controlling Painful Bone Metastases
    Lutz, Stephen
    CURRENT PAIN AND HEADACHE REPORTS, 2012, 16 (04) : 300 - 306
  • [30] Palliative Radiation Therapy for Bone Metastases in Neuroendocrine Neoplasms
    Guan, Michelle
    He, Ingrid
    Luu, Michael
    David, John
    Gong, Jun
    Placencio-Hickok, Veronica R.
    Reznik, Robert S.
    Tuli, Richard
    Hendifar, Andrew E.
    ADVANCES IN RADIATION ONCOLOGY, 2019, 4 (03) : 513 - 519